Published date: 23 April 2021

Awarded contract - This means that the contract has been awarded to a supplier.


Closing: 19 March 2021, 1pm

Contract summary

Industry

  • Influenza vaccines - 33651660

Location of contract

United Kingdom

Value of contract

£0

Procurement reference

CF-0184400D0O000000rwimUAA1

Published date

23 April 2021

Closing date

19 March 2021

Closing time

1pm

Contract start date

1 August 2021

Contract end date

31 July 2022

Contract type

Supply contract

Procedure type

Negotiated procedure without prior publication (above threshold)

The opportunity was not advertised, because for example only one supplier is capable of delivering the requirement, or due to extreme urgency brought about by unforeseen events.

This procedure can be used for procurements above the relevant contract value threshold.

Contract is suitable for SMEs?

No

Contract is suitable for VCSEs?

No

Description

The provision of a live attenuated intranasal influenza vaccine, to be used to support the annual seasonal influenza vaccination programme, which includes children. The volume requirement is 3,364,470 doses of vaccine.
Value - this information is considered by the supplier to be commercially sensitive information. The authority is not publishing the value so as not to prejudice the legitimate commercial interest of the supplier.

Award information

Awarded date

20 March 2021

Contract start date

1 August 2021

Contract end date

31 July 2022

Total value of contract

£1

This contract was awarded to 1 supplier.

AstraZeneca

Address

1 Francis Crick Avenue LCB2 0AA

Reference

None

Supplier is SME?

No

Supplier is VCSE?

No

About the buyer

Contact name

Lynne Nichols

Address

2nd Floor, Rutland House
Runcorn
WA7 2ES
GB

Email

lynne.nichols@dhsc.gov.uk